PE-backed Emmes buys IDS
Emmes, a portfolio company of Behrman Capital, has acquired Munich-based Institut Dr. Schauerte, a clinical research organization that focuses on follow-up studies.
Emmes, a portfolio company of Behrman Capital, has acquired Munich-based Institut Dr. Schauerte, a clinical research organization that focuses on follow-up studies.